Yatharth Hospital IPO: Project Delays Leave ₹48 Cr of Funds Unused

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Yatharth Hospital IPO: Project Delays Leave ₹48 Cr of Funds Unused
Overview

Yatharth Hospital & Trauma Care Services Ltd's latest monitoring report shows ₹521.26 crore of its ₹610 crore IPO funds were used by March 31, 2026, leaving ₹48.45 crore unutilised. CARE Ratings noted ongoing delays in project implementation, raising concerns about potential cost overruns and the ability to achieve project goals.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Yatharth Hospital IPO Funds: Delays Persist, ₹48 Cr Unused

Yatharth Hospital & Trauma Care Services Ltd reported that ₹521.26 crore of its ₹610 crore Initial Public Offering (IPO) proceeds had been utilized as of March 31, 2026. However, ₹48.45 crore remains unspent.

The hospital chain’s latest monitoring report, prepared by CARE Ratings Limited, flagged ongoing delays in project implementation. These delays raise concerns about potential cost overruns and the overall viability of achieving the expansion objectives.

The IPO, which raised ₹610 crore in July 2023, was intended to fund the construction of new hospitals and the expansion of existing facilities, particularly in Noida, Greater Noida, and Mathura. Yatharth Hospital primarily operates in North India, focusing on tertiary and quaternary care services.

Investors will be watching how the company addresses these execution hurdles. Persistent delays could impact the timely completion of expansion plans, potentially affecting future revenue growth. The efficient deployment of the remaining ₹48.45 crore will also be a key focus for shareholders.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.